Kisely Steve R, Campbell Leslie A, O'Reilly Richard
School of Medicine, The University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland, Australia, QLD 4102.
Department of Community Health and Epidemiology, Dalhousie University, Room 415, 5790 University Avenue, Halifax, NS, Canada, B3K 1V7.
Cochrane Database Syst Rev. 2017 Mar 17;3(3):CD004408. doi: 10.1002/14651858.CD004408.pub5.
It is controversial whether compulsory community treatment (CCT) for people with severe mental illness (SMI) reduces health service use, or improves clinical outcome and social functioning.
To examine the effectiveness of compulsory community treatment (CCT) for people with severe mental illness (SMI).
We searched the Cochrane Schizophrenia Group's Study-Based Register of Trials (2003, 2008, 2012, 8 November 2013, 3 June 2016). We obtained all references of identified studies and contacted authors where necessary.
All relevant randomised controlled clinical trials (RCTs) of CCT compared with standard care for people with SMI (mainly schizophrenia and schizophrenia-like disorders, bipolar disorder, or depression with psychotic features). Standard care could be voluntary treatment in the community or another pre-existing form of CCT such as supervised discharge.
Authors independently selected studies, assessed their quality and extracted data. We used Cochrane's tool for assessing risk of bias. For binary outcomes, we calculated a fixed-effect risk ratio (RR), its 95% confidence interval (95% CI) and, where possible, the number needed to treat for an additional beneficial outcome (NNTB). For continuous outcomes, we calculated a fixed-effect mean difference (MD) and its 95% CI. We used the GRADE approach to create 'Summary of findings' tables for key outcomes and assessed the risk of bias of these findings.
The review included three studies (n = 749). Two were based in the USA and one in England. The English study had the least bias, meeting three out of the seven criteria of Cochrane's tool for assessing risk of bias. The two other studies met only one criterion, the majority being rated unclear.Two trials from the USA (n = 416) compared court-ordered 'outpatient commitment' (OPC) with entirely voluntary community treatment. There were no significant differences between OPC and voluntary treatment by 11 to 12 months in any of the main health service or participant level outcome indices: service use - readmission to hospital (2 RCTs, n= 416, RR 0.98, 95% CI 0.79 to 1.21, low-quality evidence); service use - compliance with medication (2 RCTs, n = 416, RR 0.99, 95% CI 0.83 to 1.19, low-quality evidence); social functioning - arrested at least once (2 RCTs, n = 416, RR 0.97, 95% CI 0.62 to 1.52, low-quality evidence); social functioning - homelessness (2 RCTs, n = 416, RR 0.67, 95% CI 0.39 to 1.15, low-quality evidence); or satisfaction with care - perceived coercion (2 RCTs, n = 416, RR 1.36, 95% CI 0.97 to 1.89, low-quality evidence). However, one trial found the risk of victimisation decreased with OPC (1 RCT, n = 264, RR 0.50, 95% CI 0.31 to 0.80, low-quality evidence).The other RCT compared community treatment orders (CTOs) with less intensive and briefer supervised discharge (Section 17) in England. The study found no difference between the two groups for either the main health service outcomes including readmission to hospital by 12 months (1 RCT, n = 333, RR 0.99, 95% CI 0.74 to 1.32, moderate-quality evidence), or any of the participant level outcomes. The lack of any difference between the two groups persisted at 36 months' follow-up.Combining the results of all three trials did not alter these results. For instance, participants on any form of CCT were no less likely to be readmitted than participants in the control groups whether on entirely voluntary treatment or subject to intermittent supervised discharge (3 RCTs, n = 749, RR for readmission to hospital by 12 months 0.98, 95% CI 0.82 to 1.16 moderate-quality evidence). In terms of NNTB, it would take 142 orders to prevent one readmission. There was no clear difference between groups for perceived coercion by 12 months (3 RCTs, n = 645, RR 1.30, 95% CI 0.98 to 1.71, moderate-quality evidence).There were no data for adverse effects.
AUTHORS' CONCLUSIONS: These review data show CCT results in no clear difference in service use, social functioning or quality of life compared with voluntary care or brief supervised discharge. People receiving CCT were, however, less likely to be victims of violent or non-violent crime. It is unclear whether this benefit is due to the intensity of treatment or its compulsory nature. Short periods of conditional leave may be as effective (or non-effective) as formal compulsory treatment in the community. Evaluation of a wide range of outcomes should be considered when this legislation is introduced. However, conclusions are based on three relatively small trials, with high or unclear risk of blinding bias, and low- to moderate-quality evidence. In addition, clinical trials may not fully reflect the potential benefits of this complex intervention.
对于严重精神疾病(SMI)患者实施强制社区治疗(CCT)是否能减少医疗服务使用、改善临床结局及社会功能,存在争议。
探讨强制社区治疗(CCT)对严重精神疾病(SMI)患者的有效性。
我们检索了Cochrane精神分裂症研究组基于研究的试验注册库(2003年、2008年、2012年、2013年11月8日、2016年6月3日)。我们获取了已识别研究的所有参考文献,并在必要时联系了作者。
所有将CCT与严重精神疾病(SMI)患者的标准治疗(主要为精神分裂症及精神分裂症样障碍、双相情感障碍或伴有精神病性特征的抑郁症)进行比较的相关随机对照临床试验(RCT)。标准治疗可以是社区中的自愿治疗或另一种现有的CCT形式,如监督出院。
作者独立选择研究、评估其质量并提取数据。我们使用Cochrane偏倚风险评估工具。对于二分类结局,我们计算固定效应风险比(RR)及其95%置信区间(95%CI),并在可能的情况下计算额外有益结局的需治疗人数(NNTB)。对于连续性结局,我们计算固定效应平均差(MD)及其95%CI。我们使用GRADE方法为关键结局创建“结果总结”表,并评估这些结果的偏倚风险。
该综述纳入了三项研究(n = 749)。两项在美国进行,一项在英国进行。英国的研究偏倚最小,符合Cochrane偏倚风险评估工具七个标准中的三个。另外两项研究仅符合一个标准,大多数被评为不清楚。美国的两项试验(n = 416)比较了法院命令的“门诊治疗承诺”(OPC)与完全自愿的社区治疗。在任何主要的医疗服务或参与者层面结局指标上,11至12个月时OPC与自愿治疗之间均无显著差异:医疗服务使用——再次入院(2项RCT,n = 416,RR 0.98,95%CI 0.79至1.21,低质量证据);医疗服务使用——药物依从性(2项RCT,n = 416,RR 0.99,95%CI 0.83至1.19,低质量证据);社会功能——至少被捕一次(2项RCT,n = 416,RR 0.97,95%CI 0.62至1.52,低质量证据);社会功能——无家可归(2项RCT,n = 416,RR 0.67,95%CI 0.39至1.15,低质量证据);或对护理的满意度——感知到的强制(2项RCT,n = 416,RR 1.36,95%CI 0.97至1.89,低质量证据)。然而,一项试验发现OPC可降低受侵害风险(1项RCT,n = 264,RR 0.50,95%CI 0.31至0.80,低质量证据)。另一项RCT在英国比较了社区治疗令(CTO)与强度较低且时间较短的监督出院(第17节)。该研究发现,两组在主要医疗服务结局(包括12个月内再次入院,1项RCT,n = 333,RR 0.99,95%CI 0.74至1.32,中等质量证据)或任何参与者层面结局上均无差异。两组之间在36个月随访时仍无差异。合并所有三项试验的结果并未改变这些结果。例如,接受任何形式CCT的参与者与对照组参与者(无论是完全自愿治疗还是接受间歇性监督出院)相比,再次入院的可能性并无降低(3项RCT,n = 749,12个月内再次入院的RR为0.98,95%CI 0.82至1.16,中等质量证据)。就NNTB而言,需要142项命令才能预防一次再次入院。12个月时两组在感知到的强制方面无明显差异(3项RCT,n = 645,RR 1.30,95%CI 0.98至1.71,中等质量证据)。无不良反应数据。
这些综述数据表明,与自愿护理或短期监督出院相比,CCT在医疗服务使用、社会功能或生活质量方面并无明显差异。然而,接受CCT的人成为暴力或非暴力犯罪受害者的可能性较小。尚不清楚这种益处是由于治疗强度还是其强制性。短期的有条件休假在社区中可能与正式的强制治疗同样有效(或无效)。引入该立法时应考虑对广泛结局进行评估。然而,结论基于三项相对较小的试验,存在高或不清楚的盲法偏倚风险,且证据质量低至中等。此外,临床试验可能无法完全反映这种复杂干预的潜在益处。